<?xml version="1.0" encoding="UTF-8"?>
<ref id="B94">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kleymann</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Fischer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Betz</surname>
    <given-names>U. A. K.</given-names>
   </name>
   <name>
    <surname>Hendrix</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bender</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Schneider</surname>
    <given-names>U.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2002</year>). 
  <article-title>New helicase-primase inhibitors as drug candidates for the treatment of herpes simplex disease.</article-title>
  <source>
   <italic>Nat. Med.</italic>
  </source>
  <volume>8</volume>
  <fpage>392</fpage>â€“
  <lpage>398</lpage>. 
  <pub-id pub-id-type="doi">10.1038/nm0402-392</pub-id>
  <?supplied-pmid 11927946?>
  <pub-id pub-id-type="pmid">11927946</pub-id>
 </mixed-citation>
</ref>
